Regulatory

CMS to Cover Cardiac Ablations Performed in ASCs – Cardiology Group Calls It a ‘Tremendous Victory’

The Centers for Medicare and Medicaid Services (CMS) has finalized new payment policies that will radically change the way cardiac ablation procedures are reimbursed going forward. For cardiologists, perhaps the biggest news to come out of this final rule is the fact that cardiac catheter ablation has been added to the ASC covered procedures list […]

CMS to Cover Cardiac Ablations Performed in ASCs – Cardiology Group Calls It a ‘Tremendous Victory’ Read More »

CMS Finalizes 2.6% Payment Increase for Hospital Outpatient Centers, ASCs

The Trump administration has finalized the rule that sets government payments to hospital outpatient facilities and ambulatory surgical centers, including a 2.6% rate bump for each. That is an increase from the proposed Outpatient Prospective Payment System (OPPS) rule, which pitched a 2.4% increase in the payment rate for outpatient services and ASCs. The rule

CMS Finalizes 2.6% Payment Increase for Hospital Outpatient Centers, ASCs Read More »

Dialysis Centers to Receive $180M Medicare Payment Boost

Medicare payments to hospital-based dialysis centers will increase 1.5% in 2026, while standalone clinics would see an estimated 2.2% bump in payments under a final rule released by the Trump administration. The final rule (RIN 0938-AV52) from the Centers for Medicare & Medicaid Services plans to allocate $6 billion to approximately 7,600 end-stage renal disease

Dialysis Centers to Receive $180M Medicare Payment Boost Read More »

Australia Blocks Takeover of Mayne Pharma by US Firm, Cites National Interest

Australia on Friday blocked a A$672 million ($435 million) buyout offer for Mayne Pharma (MYX.AX) from Cosette Pharmaceuticals after the U.S. drugmaker became a reluctant suitor and threatened to close a local plant. The decision by the country’s centre-left government sent shares in Mayne tumbling 23% before it halted trading pending an update on the

Australia Blocks Takeover of Mayne Pharma by US Firm, Cites National Interest Read More »

Day Kimball Hospital Could Join UConn Health Network Under New State Plan

Day Kimball Hospital is nearly all systems go to join UConn Health as legislation enabling the partnership sits on the governor’s desk awaiting signature. The state Senate passed legislation that allowed UConn Health to pursue acquisitions of hospitals. That includes Day Kimball in Putnam, northeastern Connecticut’s only hospital. The state will provide $390 million over

Day Kimball Hospital Could Join UConn Health Network Under New State Plan Read More »

State OKs UConn Health to Acquire Prospect Connecticut Hospital

The Connecticut General Assembly approved legislation on Nov. 13 for Farmington, Conn.-based UConn Health to invest in Waterbury (Conn.) Hospital, part of Los Angeles-based Prospect Medical Holdings. “The action by lawmakers marks a major milestone in UConn Health’s proposal to bring Waterbury Hospital under its stewardship following years of instability under Prospect ownership,” a Nov.

State OKs UConn Health to Acquire Prospect Connecticut Hospital Read More »

DEA Signals Readiness to Extend Telehealth and Prescribing Flexibilities for a Fourth Year

Behavioral health and addiction treatment providers are expecting renewed guidance from the Drug Enforcement Administration (DEA) around telehealth prescribing flexibilities for controlled substances, now that the longest government shutdown in the country’s history has been resolved. A pending executive order sent to the Office of Management and Budget titled “Fourth Temporary Extension of COVID-19 Telemedicine

DEA Signals Readiness to Extend Telehealth and Prescribing Flexibilities for a Fourth Year Read More »

Patients over Profit Act: A Federal Inflection Point on Insurer-Provider Integration and What Comes Next

For years, the conversation around health insurer consolidation and vertical integration has simmered through antitrust inquiries, oversight hearings, and policy papers. The Patients Over Profit Act (the “POP Act”), introduced in both chambers of Congress this fall, marks a decisive shift. Rather than regulating insurer-provider integration, the POP Act proposes to ban it outright. If

Patients over Profit Act: A Federal Inflection Point on Insurer-Provider Integration and What Comes Next Read More »

Scroll to Top